Filtros de búsqueda

Lista de obras de Kathrin Jansen

13-Valent pneumococcal conjugate vaccine in older children and adolescents either previously immunized with or naïve to 7-valent pneumococcal conjugate vaccine

artículo científico publicado en 2014

13-valent pneumococcal conjugate vaccine immune sera protects against pneumococcal serotype 1, 3, and 5 bacteremia in a neonatal rat challenge model ⬇️

artículo científico publicado el 1 de enero de 2011

1337. Development, Maintenance, and Application of Opsonophagocytic Assays to Measure Functional Antibody Responses to Support a 20 Valent Pneumococcal Conjugate Vaccine

244. Development, Qualification, and Clinical Validation of an Immunodiagnostic assay for the Detection of 11 Additional S. pneumoniae Serotype-Specific Polysaccharides in Human Urine

2755. Phase 1/2, First-in-Human Study of the Safety, Tolerability, and Immunogenicity of an RSV Prefusion F-Based Subunit Vaccine Candidate

2781. Statistical Modeling to Predict Maternal RSV Vaccine Efficacy from Neutralizing Titers

599Rapid rises in antibody titers observed following single dose administration of a novel 4-antigen Staphylococcus aureus vaccine (SA4Ag) to healthy adults.

artículo científico publicado en 2014

A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults

artículo científico publicado en 2017

A Longitudinal Epidemiology Study of Meningococcal Carriage in Students 13 to 25 Years Old in Quebec

artículo científico publicado en 2018

A Novel Hexavalent Capsular Polysaccharide Conjugate Vaccine (GBS6) for the Prevention of Neonatal Group B Streptococcal Infections by Maternal Immunization.

artículo científico publicado en 2019

A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years

artículo científico publicado en 2020

A Phase 2, Randomized, Active-controlled, Observer-blinded Study to Assess the Immunogenicity, Tolerability and Safety of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered With Tetanus, Diphtheria and Acellular Pertussis Vaccine

artículo científico publicado en 2016

A Recombinant Clumping Factor A-Containing Vaccine Induces Functional Antibodies to Staphylococcus aureus That Are Not Observed after Natural Exposure ⬇️

artículo científico publicado el 15 de agosto de 2012

A Vaccine Approach for the Prevention of Infections by Multidrug-resistant Enterococcus faecium

artículo científico publicado en 2015

A controlled trial of a human papillomavirus type 16 vaccine

artículo científico publicado en 2002

A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups

artículo científico publicado en 2013

A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model

artículo científico publicado en 2006

A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile.

artículo científico publicado en 2013

A phase 1 randomized study assessing safety and immunogenicity of two 3-dose regimens of a Clostridium difficile vaccine in healthy older Japanese adults

scientific article published on 05 April 2019

A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults

artículo científico publicado en 2016

A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults

artículo científico publicado en 2016

A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine

scientific article published on 01 August 2004

A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults.

artículo científico

A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents

artículo científico publicado en 2013

A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection.

artículo científico publicado en 2005

Adult vaccination

artículo científico publicado en 2015

An immunodominant NP<sub>105-113</sub>-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease

artículo científico publicado en 2021

Anti-infective vaccination in the 21st century-new horizons for personal and public health

artículo científico publicado en 2015

Approach to the Discovery, Development, and Evaluation of a Novel Neisseria meningitidis Serogroup B Vaccine

artículo científico publicado en 2016

Bactericidal activity of sera from adolescents vaccinated with bivalent rLP2086 against meningococcal serogroup B outbreak strains from France

artículo científico publicado en 2017

Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease

artículo científico publicado en 2010

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T-cell responses

artículo científico publicado en 2020

Capsular polysaccharides are an important immune evasion mechanism forStaphylococcus aureus ⬇️

artículo científico publicado el 18 de diciembre de 2012

Challenges for the evaluation of Staphylococcus aureus protein based vaccines: Monitoring antigenic diversity ⬇️

artículo científico publicado el 1 de enero de 2011

Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trial

article

Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections ⬇️

artículo científico publicado en 2015

Concurrent human antibody and TH1 type T-cell responses elicited by a COVID-19 RNA vaccine

artículo científico publicado en 2020

Covering all the Bases: Preclinical Development of an Effective Staphylococcus aureus Vaccine

artículo científico publicado en 2014

Demonstration of the preclinical correlate of protection for Staphylococcus aureus clumping factor A in a murine model of infection

artículo científico publicado en 2015

Detection of HPV in Norwegian cervical biopsy specimens with type-specific PCR and reverse line blot assays.

artículo científico publicado en 2006

Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide

artículo científico publicado en 2009

Detection of specific human papillomavirus types in paraffin-embedded sections of cervical carcinomas

scientific article published on 01 January 2006

Development and Validation of 13-plex Luminex-Based Assay for Measuring Human Serum Antibodies to Capsular Polysaccharides

article

Development of a multicomponentStaphylococcus aureusvaccine designed to counter multiple bacterial virulence factors ⬇️

artículo científico publicado el 24 de agosto de 2012

Development of a subunit vaccine for prevention of Clostridium difficile associated diseases: Biophysical characterization of toxoids A and B.

artículo científico publicado en 2017

Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumonia ⬇️

artículo científico publicado el 8 de febrero de 2013

Differences between culture & non-culture confirmed invasive meningococci with a focus on factor H-binding protein distribution

artículo científico publicado en 2016

Distinct fibroblast subsets drive inflammation and damage in arthritis

scientific article published on 29 May 2019

Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women

artículo científico publicado en 2004

Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine

artículo científico publicado en 2004

Effect of vaccine delivery system on the induction of HPV16L1-specific humoral and cell-mediated immune responses in immunized rhesus macaques

artículo científico publicado en 2003

Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia

artículo científico publicado en 2006

Estimated susceptibility of Canadian meningococcal B isolates to a meningococcal serogroup B vaccine (MenB-FHbp)

scientific article published on 23 January 2020

Evaluation of a Validated Luminex-Based Multiplex Immunoassay for Measuring Immunoglobulin G Antibodies in Serum to Pneumococcal Capsular Polysaccharides

scientific article published in 2018

Evaluation of a multilocus sequence typing system for Staphylococcus epidermidis ⬇️

artículo científico publicado el 1 de noviembre de 2003

Evaluation of approaches to monitor Staphylococcus aureus virulence factor expression during human disease.

artículo científico publicado en 2015

From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine

artículo científico publicado en 2018

Group A Streptococcal Carriage and Seroepidemiology in Children up to 10 Years of Age in Australia.

artículo científico publicado en 2015

Heterogeneous in vivo expression of clumping factor A and capsular polysaccharide by Staphylococcus aureus: implications for vaccine design

artículo científico publicado en 2009

Human antibody responses to the meningococcal factor H binding protein (LP2086) during invasive disease, colonization and carriage.

artículo científico publicado en 2010

Human papillomavirus type 6 virus-like particles present overlapping yet distinct conformational epitopes

artículo científico publicado en 2003

Human papillomavirus vaccines and prevention of cervical cancer

artículo científico publicado en 2004

Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers ⬇️

artículo científico publicado el 23 de agosto de 2010

Immunogenicity and reactogenicity of a novel vaccine for human papillomavirus 16: a 2-year randomized controlled clinical trial

scientific article published on 01 May 2005

Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine (PCV13) formulated with 2-phenoxyethanol in multidose vials given with routine vaccination in healthy infants: An open-label randomized controlled trial

artículo científico publicado en 2017

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults ⬇️

artículo científico publicado el 18 de mayo de 2013

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination

artículo científico publicado en 2015

Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents

artículo científico

Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus Vaccine

artículo científico publicado en 2016

Immunogenicity, safety, and tolerability of the meningococcal serogroup B bivalent rLP2086 vaccine in adult laboratory workers

artículo científico publicado en 2015

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

scientific article published on 15 May 2006

Importance of specimen type in detecting human papillomavirus DNA from the female genital tract

artículo científico publicado en 2009

Infectious virions produced from a human papillomavirus type 18/16 genomic DNA chimera

artículo científico publicado en 2002

Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older ⬇️

artículo científico publicado el 18 de mayo de 2013

Introduction

Isolation, structural characterization, and immunological evaluation of a high-molecular-weight exopolysaccharide from Staphylococcus aureus

artículo científico publicado en 2003

Kinetics and isotype profile of antibody responses in rhesus macaques induced following vaccination with HPV 6, 11, 16 and 18 L1-virus-like particles formulated with or without Merck aluminum adjuvant

artículo científico publicado en 2005

Longitudinal multiparameter single-cell analysis of macaques immunized with pneumococcal protein-conjugated or unconjugated polysaccharide vaccines reveals distinct antigen specific memory B cell repertoires

artículo científico publicado en 2017

Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents.

artículo científico publicado en 2015

Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy

artículo científico publicado en 2015

Meningococcal serogroup B vaccines: Estimating breadth of coverage

artículo científico publicado en 2017

Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial.

artículo científico publicado en 2016

Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United States

scientific article published in PLoS ONE

Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference sera

artículo científico publicado en 2010

Multiplex Urinary Antigen Detection for 13 Streptococcus pneumoniae Serotypes Improves Diagnosis of Pneumococcal Pneumonia in South African HIV-Infected Adults

artículo científico publicado en 2016

Neisseria meningitidis Serogroup B Vaccine, Bivalent rLP2086, Induces Broad Serum Bactericidal Activity Against Diverse Invasive Disease Strains Including Outbreak Strains

artículo científico publicado en 2016

New frontiers in meningococcal vaccines ⬇️

artículo científico publicado el 1 de mayo de 2011

Non-propagating, recombinant vesicular stomatitis virus vectors encoding respiratory syncytial virus proteins generate potent humoral and cellular immunity against RSV and are protective in mice ⬇️

artículo científico publicado el 20 de diciembre de 2012

Nonreplicating vaccines can protect african green monkeys from the memphis 37 strain of respiratory syncytial virus

artículo científico publicado en 2013

Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18

artículo científico publicado en 2005

Optimization of Molecular Approaches to Genogroup Neisseria meningitidis Carriage Isolates and Implications for Monitoring the Impact of New Serogroup B Vaccines

artículo científico publicado en 2015

Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents

scientific article published on 12 February 2019

Persistence of Immune Responses Through 36 Months in Healthy Adults After Vaccination With a Novel Staphylococcus aureus 4-Antigen Vaccine (SA4Ag)

scientific article published on 24 December 2019

Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults

artículo científico publicado en 2019

Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report

preprint

Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults

scientific article published on 12 August 2020

Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.

artículo científico publicado en 2015

Poor sensitivity of polymerase chain reaction assays of genital skin swabs and urine to detect HPV 6 and 11 DNA in men.

artículo científico publicado en 2003

Potential impact of the bivalent rLP2086 vaccine onNeisseria meningitidiscarriage and invasive serogroup B disease ⬇️

artículo científico publicado el 18 de diciembre de 2012

Preclinical evidence for the potential of a bivalent fHBP vaccine to prevent Neisseria meningitidis Serogroup C Disease ⬇️

artículo científico publicado el 1 de enero de 2011

Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine

artículo científico publicado en 2018

Preservative of choice for Prev(e)nar 13™ in a multi-dose formulation ⬇️

artículo científico publicado el 7 de junio de 2011

Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States

scientific article published on 13 May 2011

Prevention of cervical cancer: journey to develop the first human papillomavirus virus-like particle vaccine and the next generation vaccine

artículo científico

Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine

artículo científico publicado en 2002

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

artículo científico publicado en 2005

Protection of beagle dogs from mucosal challenge with canine oral papillomavirus by immunization with recombinant adenoviruses expressing codon-optimized early genes

article

Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development

scientific article published on April 2009

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

artículo científico publicado en 2020

Real-time monitoring of bacterial infection in vivo: development of bioluminescent staphylococcal foreign-body and deep-thigh-wound mouse infection models

artículo científico publicado en 2003

Reevaluation of Positivity Cutoff Values for the Pneumococcal Urinary Antigen Detection Assay

artículo científico publicado en 2017

Regulation of Staphylococcus aureus MntC expression and its role in response to oxidative stress

artículo científico publicado en 2013

S. aureus colonization in healthy Australian adults receiving an investigational S. aureus 3-antigen vaccine

scientific article published on 01 October 2019

SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies

artículo científico publicado en 2017

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine ⬇️

scientific article published on 10 December 2020

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

artículo científico publicado en 2020

Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine formulations with and without aluminum phosphate and comparison of the formulation of choice with 23-valent pneumococcal polysaccharide vaccine in elderly adults: a randomized ope

artículo científico publicado en 2014

Safety and immunogenicity of a booster dose of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults: A randomized phase 1 study

artículo científico

Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: a phase 1 randomized-controlled clinical trial

artículo científico publicado en 2012

Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial

artículo científico publicado en 2020

Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents

artículo científico publicado en 2021

Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age

scientific article published on 27 July 2020

Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial ⬇️

artículo científico publicado el 7 de mayo de 2012

Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study

artículo científico publicado en 2016

Safety, tolerability, and immunogenicity of a novel 4-antigen Staphylococcus aureus vaccine (SA4Ag) in healthy Japanese adults

artículo científico publicado en 2018

Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial

artículo científico publicado en 2016

Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany

artículo científico publicado en 2010

Selection of diverse strains to assess broad coverage of the bivalent FHbp meningococcal B vaccine

artículo científico publicado en 2020

Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis

artículo científico publicado en 2009

Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60-64 years of age.

artículo científico

Seroprevalence and genital DNA prevalence of HPV types 6, 11, 16 and 18 in a cohort of young Norwegian women: study design and cohort characteristics

article

Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay

artículo científico publicado en 2003

Staphylococcus aureus Clumping Factor A Remains a Viable Vaccine Target for Prevention of S. aureus Infection

artículo científico publicado en 2016

Staphylococcus aureus Manganese Transport Protein C Is a Highly Conserved Cell Surface Protein That Elicits Protective Immunity Against S. aureus and Staphylococcus epidermidis ⬇️

artículo científico publicado el 2 de abril de 2012

Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention

artículo científico publicado en 2016

The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.

artículo científico publicado en 2011

The Dual Role of Lipids of the Lipoproteins in Trumenba, a Self-Adjuvanting Vaccine Against Meningococcal Meningitis B Disease.

artículo científico publicado en 2016

The discovery and development of a novel vaccine to protect against Neisseria meningitidis Serogroup B Disease

artículo científico publicado en 2014

The path to developing a cervical cancer vaccine ⬇️

artículo científico publicado el 1 de octubre de 2010

The role of vaccines in fighting antimicrobial resistance (AMR)

artículo científico publicado en 2018

The role of vaccines in preventing bacterial antimicrobial resistance

artículo científico publicado en 2018

Three-dimensional structure and biophysical characterization of Staphylococcus aureus cell surface antigen-manganese transporter MntC

artículo científico publicado en 2013

Toward vaccines against cervical cancer.

artículo científico publicado en 2004

Turning the corner on therapeutic cancer vaccines

artículo científico publicado en 2019

Two Vaccines for Induce a B-Cell-Mediated Immune Response

artículo científico publicado en 2018

Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia

artículo científico publicado en 2011

Vaccination against Nosocomial Infections in Elderly Adults

scientific article published on 09 April 2020

Vaccination strategies for the prevention of meningococcal disease.

artículo científico publicado en 2018

Vaccine Technology III: An ECI Conference held in Puerto Vallarta, Mexico from June 6–11, 2010

scientific article published on 07 July 2011

Vaccine innovations for emerging infectious diseases-a symposium report

scientific article published on 28 October 2019

Vaccine review: “Staphyloccocus aureus vaccines: Problems and prospects” ⬇️

artículo científico publicado el 23 de abril de 2013

Vaccines against cervical cancer

artículo científico publicado en 2004

Validation of an Immunodiagnostic Assay for Detection of 13 Streptococcus pneumoniae Serotype-Specific Polysaccharides in Human Urine ⬇️

artículo científico publicado el 6 de junio de 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda